24
Jun
2025

Hubei Lingsheng Pharmaceuticals Co., Ltd.

Exhibitor at CPHI & PMEC China 2025 stand W4A80, Pharma Ingredients
About Us

Hubei Lingsheng Pharma  was established on December 29, 2010 and headquarter in Xiangyang, Hubei Province with an area of more than 230 mu. We are a professional pharmaceutical enterprise, covering R&D, production, distribution and technical services of a whole industry chain for oral cephalosporin antibiotics, include Key intermediates, APIs and Preparations. such as 7-AVCA, 7-APRA, 7-ATCA, 7-AMCA, 7-ANCA, 7-ANCE, 7-ACCA, BCN, BT, BAPA, CHS, 3-OH and Cefditoren Pivoxil, Cefcapene Pivoxil Hydrochloride, Cefpodoxime proxetil, Ceftibuten.,etc.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2023
    On CPHI since
  • 1
    Certificates
  • 500 - 999
    Employees
Company types
Pharmaceutical company
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2025
  • 24 Jun 2025 - 26 Jun 2025
  • Shanghai New International Expo Center
  • Visit us at stand W4A80, Pharma Ingredients

Products Featured at CPHI & PMEC China 2025

  • 7-ACCA

    Product 7-ACCA

    头孢克洛母核(Intermediate of Cefaclor)

  • Cefpodoxime Proxetil

    Product Cefpodoxime Proxetil

    Cefpodoxime Proxetil
  • Cefixime trihydrate

    Product Cefixime trihydrate

    Cefixime trihydrate

  • Ceftibuten Dhydrate

    Product Ceftibuten Dhydrate

    产品名称（Product name）：头孢布烯Ceftibuten Dhydrate

  • 7-AVCA

    Product 7-AVCA

    产品名称（Product name）：7-AVCA
    头孢克肟、头孢地尼母核(Intermediate of Cefixime&Cefdinir)